Literature DB >> 20211962

The quest to eliminate intrathecal vincristine errors: a 40-year journey.

Douglas J Noble1, Liam J Donaldson.   

Abstract

BACKGROUND: Intrathecal administration of vincristine is a rare event but catastrophic for the patient, family and clinical team involved. Analysis of this source of harm shows it to be a classic systems error which has proved intractable for nearly 40 years. Failure to learn from history, communicate safety solutions nationally and internationally, create safety agencies which effectively and reliably prevent adverse events, conduct investigations and enquiries which fully reveals how to mitigate system error, develop robust physical design solutions to prevent harm to patients, make effective solutions universal and preparing for the unexpected are all major challenges.
CONCLUSIONS: The elimination of rare yet catastrophic errors like this remains one of the tests of whether we can make healthcare safer. In this paper, we discuss why effective learning has been so slow and illustrate lessons for other fields of patient safety.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211962     DOI: 10.1136/qshc.2008.030874

Source DB:  PubMed          Journal:  Qual Saf Health Care        ISSN: 1475-3898


  3 in total

1.  Prescribing Errors in UK Hospitals: Problems and Solutions.

Authors:  Ross A Breckenridge
Journal:  Ann Med Surg (Lond)       Date:  2012-02-18

2.  Identifying systems failures in the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids.

Authors:  Bryony Dean Franklin; Sukhmeet S Panesar; Charles Vincent; Liam J Donaldson
Journal:  BMJ Qual Saf       Date:  2014-03-18       Impact factor: 7.035

Review 3.  Neuraxial and peripheral misconnection events leading to wrong-route medication errors: a comprehensive literature review.

Authors:  Eugene R Viscusi; Vincent Hugo; Klaus Hoerauf; Frederick S Southwick
Journal:  Reg Anesth Pain Med       Date:  2020-11-03       Impact factor: 6.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.